September 9, 2021
BOSTON -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE). The NDE will be a secure environment to find, access, query and analyze data from select NIAID repositories, [...]
September 9, 2021
Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion [...]
Cytiva triples single-use consumables capacity in China
September 9, 2021
Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region. With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve manufacturing [...]
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
September 9, 2021
– Research collaboration covers multiple antibody research programs – SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries [...]
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
September 9, 2021
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the United Nations campaign Race to Zero. "Human health and the health of our environment are intertwined. At Illumina, [...]
September 9, 2021
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins. Named NGL-Impact® A Hi pH, the new ligand [...]
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors
September 9, 2021
Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited [...]
Optibrium Releases 3D Ligand-based Design Module for StarDrop Drug Discovery Software
September 9, 2021
Innovative predictive methods support virtual screening and compound design in the absence of 3D structure data CAMBRIDGE, UK: Optibrium Ltd, a developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation and data analysis. StarDrop is used by more than 160 [...]
September 8, 2021
New offering and other food testing technologies and workflows can be experienced through innovative PerkinElmer virtual reality demo lab environment WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today launched its IndiScope™ raw milk analysis solution. The solution is designed to help milk collection points perform fast and accurate testing to determine fair market [...]
September 8, 2021
SAN DIEGO -- Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its new Protein on Demand™ semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins enables rapid access to [...]

